This information reflects public disclosures current as of August 10, 2020
Baudax Bio’s product pipeline will evolve over time as the products move through the drug development process. This description contains forward-looking statements that involve significant risks and uncertainties, including those discussed in Baudax Bio’s filings with the Securities and Exchange Commission, and actual results may vary materially. Baudax is providing this information as of the date above and does not undertake any obligation to update any forward-looking statements contained in this table as a result of new information, future events or otherwise.